Skip to content
★ Sign in to follow
WF

Wildon Farwell

Directeur Médical
Total declarations
27
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (21 ops.)
€879k

Latest filing published 20 Aug 2024 for Dyne Therapeutics, Inc., €84k.

Filing timeline

BuySale
Wildon Farwell

Insider track record

Disclosed buys
0
Disclosed sells
21

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Wildon Farwell: trading record in brief

Wildon Farwell, listed as senior executive, appears in our data through filings on Dyne Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 27 filings, for trades running from 2 March 2021 to 19 August 2024.

The open-market record consists of 21 sales worth €879k, with no purchase. Besides market trades, the filings include 4 share grants. Since January 2024: no purchases and 13 sales on the market.

On 20 August 2024 came the latest disclosure, an open-market sale for €11k in Dyne Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Wildon Farwell

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total

19 of 19 declarations